ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding ImmunityBio, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of IBRX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	118	4	132	+18
Shares	39.1M	51.8K	49.9M	+10.8M (+27.6%)
Value	$108.7M	$138.1K	$84.1M	−$24.5M (−22.5%)

4 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held ImmunityBio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IBRX in Q3 2023
Institution	Shares	Value	% of portfolio
Armistice Capital, LLC	3,476,000	$5.87M	0.17%
Group One Trading, L.P.	446,743	$755.0K	0.03%
CVI Holdings, LLC	226,916	$383.5K	0.76%
Stonehage Fleming Financial Services Holdings Ltd	85,000	$143.7K	0.01%
Verition Fund Management LLC	84,770	$143.3K	0.00%
Rathbone Brothers plc	73,420	$124.1K	0.00%
Bank of Montreal	48,360	$87.0K	0.00%
Millennium Management LLC	44,161	$74.6K	0.00%
Two Sigma Securities, LLC	33,980	$57.4K	0.00%
SG Americas Securities, LLC	33,697	$57.0K	0.00%
Beacon Pointe Advisors, LLC	26,042	$44.0K	0.00%
JustInvest LLC	21,606	$36.5K	0.00%
Pictet Asset Management Holding SA	21,556	$36.4K	0.00%
Point72 Asset Management, L.P.	15,500	$26.2K	0.00%
Winton Group Ltd	15,438	$26.1K	0.00%
Traynor Capital Management, Inc.	14,950	$25.3K	0.00%
Aire Advisors, LLC	14,768	$25.0K	0.01%
Victory Capital Management Inc	14,029	$23.7K	0.00%
Engineers Gate Manager LP	13,632	$23.0K	0.00%
LPL Financial LLC	12,917	$21.8K	0.00%
Legacy Advisors, LLC	12,500	$21.1K	0.00%
Moss Adams Wealth Advisors LLC	12,341	$20.9K	0.01%
Eqis Capital Management, Inc.	11,409	$19.3K	0.00%
Callan Capital, LLC	10,555	$17.8K	0.00%
Simplex Trading, LLC	8,883	$15.0K	0.00%
Parallel Advisors, LLC	1,000	$1.69K	0.00%
Avion Wealth	696	$1.00K	0.00%
Wolff Wiese Magana LLC	500	$845	0.00%
Nisa Investment Advisors, LLC	233	$394	0.00%

Sold out (11)

Institutions that held ImmunityBio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of IBRX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Dark Forest Capital Management LP	203,659	$566.2K
Balyasny Asset Management LLC	193,285	$537.3K
Jane Street Group, LLC	146,732	$407.9K
Wolverine Trading, LLC	32,178	$87.5K
Jump Financial, LLC	22,635	$62.9K
Ameriprise Financial Inc	22,400	$62.3K
Man Group plc	10,242	$28.5K
Ascent Wealth Partners, LLC	10,000	$27.8K
Worth Asset Management, LLC	1,550	$4.31K
Parallax Volatility Advisers, L.P.	297	$826
GWM Advisors LLC	250	$695

Not filed for Q3 2023 yet (4)

Institutions that held ImmunityBio, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	21,556	$59.9K
Bell & Brown Wealth Advisors, LLC	20,100	$55.9K
Endurance Wealth Management, Inc.	10,000	$22.0K
BerganKDV Wealth Management, LLC	115	$320